Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pharmacogenetic Implications for Antidepressant Pharmacotherapy in Late-Life Depression: A Systematic Review of the Literature for Response, Pharmacokinetics and Adverse Drug Reactions

American Journal of Geriatric Psychiatry(2020)10.1016/j.jagp.2020.01.007Source: DataRank Database

Pharmacogenetic Implications for Antidepressant Pharmacotherapy in Late-Life Depression: A Systematic Review of the Literature for Response, Pharmacokinetics and Adverse Drug Reactions is a research paper published in American Journal of Geriatric Psychiatry (2020). On theSindex it has a DataRank of 0. It has been cited 38 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

38 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.22)OA: closedTopics (30)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Farhana Islam ORCID,Małgorzata Maciukiewicz ORCID,Chad Bousman ORCID,Harris A. Eyre ORCID,Helen Lavretsky ORCID

Live enrichment

PubMed:32122803 OpenAlex:https://openalex.org/W3005041247

Canadian Institutes of Health Research

Grant: 81655

Canadian Institutes of Health Research

Grant: 394160

NIH

Washington University

CIHR

FWCI

1.22

Citation Percentile

0.7%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

closedLicense: https://www.elsevier.com/legal/tdmrep-license

publisherhttps://api.elsevier.com/content/article/PII:S1064748120300208?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1064748120300208?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jagp.2020.01.007

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32122803

Fields of Study

Treatment of Major DepressionTryptophan and brain disordersDiet and metabolism studies

MeSH Terms

AgedAntidepressive AgentsMajor Depressive DisorderDepressive Disorder, MajorHumansPharmacogeneticsTreatment OutcomeBrain-Derived Neurotrophic FactorCytochrome P-450 CYP2D6Serotonin Plasma Membrane Transport Proteins

Keywords

AntidepressantPharmacogeneticsPharmacotherapyDepression (economics)PharmacokineticsMedicineAdverse effectDrugPharmacologyIntensive care medicinePsychiatryBiologyGenotypeAnxietyResponseTreatment OutcomesLate-life Depression

Sustainable Development Goals

SDG 0: Good health and well-being